Manufacturing

India’s largest cement producer, UltraTech Cement, has reached a settlement in a prolonged dispute concerning its Dalla Super manufacturing unit, bringing clarity to a matter that had lingered over operational and regulatory issues. The resolution is expected to remove legal uncertainty surrounding the facility and allow the company to focus on production optimization and strategic growth. Industry observers say the settlement highlights the importance of regulatory alignment and dispute resolution in capital-intensive sectors like cement manufacturing.

India’s largest automaker, Maruti Suzuki India, has announced a major capital investment of Rs. 10,189 crore to expand its manufacturing operations in Gujarat. The strategic investment aims to increase production capacity, strengthen supply chains and support the company’s long-term growth strategy in India’s rapidly evolving automobile market. The expansion reflects rising demand for passenger vehicles and the company’s focus on maintaining market leadership through scale and operational efficiency.

Honda Motorcycle & Scooter India (HMSI) has announced a significant capital infusion of Rs. 1,500 crore into its Tapukara plant, underscoring its commitment to scaling production capacity, enhancing technology adoption, and strengthening supply chain capabilities. The investment aims to support rising domestic and export demand for two-wheelers, introduce advanced manufacturing processes, and reinforce HMSI’s competitive positioning in India’s rapidly evolving automotive market.

India’s wholesale price inflation continued its upward trajectory for the fourth consecutive month in February 2026, reaching 2.13%, according to government data. The increase was primarily driven by higher prices across several sectors, including food articles, non-food commodities, basic metals, textiles, and other manufacturing segments. While vegetable prices recorded a modest month-on-month easing, broader commodity inflation contributed to the overall rise in the Wholesale Price Index (WPI).

India is taking a decisive step toward strengthening its domestic pharmaceutical supply chain with the foundation of a Rs 600 crore manufacturing facility in Kathua district of Jammu and Kashmir. The project, developed by Orchid Pharma with support from the Biotechnology Industry Research Assistance Council under the Department of Biotechnology, will produce Amino Cephalosporanic Acid (ACA), a vital intermediate used in cephalosporin antibiotics.